Marshall Fordyce
Vermogen: 15 M $ op 30-09-2026
Vermogen: 15 M $ op 30-09-2026
Marshall W.
Fordyce is the founder of Vera Therapeutics, Inc., founded in 2016, serving as President, Chief Executive Officer & Director.
Current job includes Non-Executive Director at Albert & Mary Lasker Foundation since 2012.
Former job includes Senior Director-Clinical Research at Gilead Sciences, Inc. from 2011 to 2016.
Education includes undergraduate degree from Harvard University and doctorate from Harvard Medical School.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 15-09-2026 | 457.274 ( 0,63% ) | 15 M $ | 30-09-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| VERA THERAPEUTICS, INC. | Oprichter | 01-05-2016 |
Albert & Mary Lasker Foundation
Albert & Mary Lasker Foundation The Albert & Mary Lasker Foundation is a U.S.-based 501(c)(3) nonprofit organization dedicated to improving health by accelerating support for medical research through recognition of research excellence, advocacy, and education. The private company is based in New York, NY. The foundation emphasizes advancing biomedical science and fostering public understanding of medical research. It organizes the annual Lasker Awards to honor achievements in medical science and hosts educational initiatives such as the Lasker Lectures and a video contest for early-career scientists and clinicians to communicate important biological and medical issues. In partnership with the National Institutes of Health (NIH), the foundation administers the Lasker Clinical Research Scholars Program, providing funding to early-career clinician-researchers to conduct independent research within the NIH intramural research program. The foundation also collaborates with organizations to produce free educational videos and storytelling content that highlight the scientific process and biological discoveries. | Directeur/Bestuurslid | 01-04-2012 |
| Bedrijven | Functie | Einde |
|---|---|---|
| GILEAD SCIENCES, INC. | Hoofd Techniek/Wetenschap/O&O | 01-07-2016 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
Gilead Sciences, Inc.
Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Albert & Mary Lasker Foundation
Albert & Mary Lasker Foundation The Albert & Mary Lasker Foundation is a U.S.-based 501(c)(3) nonprofit organization dedicated to improving health by accelerating support for medical research through recognition of research excellence, advocacy, and education. The private company is based in New York, NY. The foundation emphasizes advancing biomedical science and fostering public understanding of medical research. It organizes the annual Lasker Awards to honor achievements in medical science and hosts educational initiatives such as the Lasker Lectures and a video contest for early-career scientists and clinicians to communicate important biological and medical issues. In partnership with the National Institutes of Health (NIH), the foundation administers the Lasker Clinical Research Scholars Program, providing funding to early-career clinician-researchers to conduct independent research within the NIH intramural research program. The foundation also collaborates with organizations to produce free educational videos and storytelling content that highlight the scientific process and biological discoveries. | |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vera Therapeutics, Inc.
Vera Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which focuses on development and treatments for immunological & inflammatory diseases | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau